Your browser doesn't support javascript.
loading
Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort Study.
Singal, Amit G; Parikh, Neehar D; Shetty, Kirti; Han, Steven-Huy; Xie, Cassie; Ning, Jing; Rinaudo, Jo Ann; Arvind, Ashwini; Lok, Anna S; Kanwal, Fasiha.
Affiliation
  • Singal AG; Division of Digestive and Liver Diseases, University of Texas Southwestern, Dallas, Texas, USA.
  • Parikh ND; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Shetty K; Division of Gastroenterology and Hepatology, University of Maryland, Baltimore, Maryland, USA.
  • Han SH; Pfleger Liver Institute, Vatche and Tamar Manoukian Division of Digestive Diseases, UCLA, Los Angeles, California, USA.
  • Xie C; Department of Biostatistics, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Ning J; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Rinaudo JA; National Cancer Institute, Bethesda, Maryland, USA.
  • Arvind A; Division of Digestive and Liver Diseases, University of Texas Southwestern, Dallas, Texas, USA.
  • Lok AS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Kanwal F; Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA.
Am J Gastroenterol ; 2024 May 29.
Article in En | MEDLINE | ID: mdl-38686922
ABSTRACT

INTRODUCTION:

Indeterminate liver nodules (ILNs) are frequently encountered on diagnostic imaging after positive hepatocellular carcinoma (HCC) surveillance results, but their natural history remains unclear.

METHODS:

We conducted a multicenter retrospective cohort study among patients with ≥1 newly detected LI-RADS 3 (LR-3) lesion ≥1 cm or LI-RADS 4 (LR-4) lesion of any size (per LI-RADS v2018) between January 2018 and December 2019. Patients were followed with repeat imaging at each site per institutional standard of care. Multivariable Fine-Gray models were used to evaluate associations between potential risk factors and patient-level time-to-HCC diagnosis, with death and liver transplantation as competing risks.

RESULTS:

Of 307 patients with ILNs, 208 had LR-3 lesions, 83 had LR-4 lesions, and 16 had both LR-3 and LR-4 lesions. HCC incidence rates for patients with LR-3 and LR-4 lesions were 110 (95% CI 70-150) and 420 (95% CI 310-560) per 1,000 person-year, respectively. In multivariable analysis, incident HCC among patients with LR-3 lesions was associated with older age, thrombocytopenia (platelet count ≤150 ×10 9 /L), and elevated serum alpha-fetoprotein levels. Among those with LR-4 lesions, incident HCC was associated with a maximum lesion diameter >1 cm. Although most patients had follow-up computed tomography or magnetic resonance imaging, 13.7% had no follow-up imaging and another 14.3% had follow-up ultrasound only.

DISCUSSION:

ILNs have a high but variable risk of HCC, with 4-fold higher risk in patients with LR-4 lesions than those with LR-3 lesions, highlighting a need for accurate risk stratification tools and close follow-up in this population.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Gastroenterol / Am. j. gastroenterol. (Online) / The American journal of gastroenterology (Online) Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Gastroenterol / Am. j. gastroenterol. (Online) / The American journal of gastroenterology (Online) Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos